Evidence map›Paper›PMID 25763266›Full record

ArticleIranian Red Crescent medical journal2015

Trial of tramadol plus gabapentin for opioid detoxification.

Hassan Ziaaddini, Ahmad Ziaaddini, Neda Asghari, Nozar Nakhaee, Mahin Eslami

Open access · bronzeAbstract read
In one paragraph

Article in Iranian Red Crescent medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pharmacological therapies for management of opium withdrawal.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Gabapentin for the treatment of alcohol use disorder.Expert opinion on investigational drugs · 2018
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hassan ZiaaddiniDepartment of Psychiatry, Kerman University of Medical Sciences, Kerman, IR Iran.
Ahmad ZiaaddiniKerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, IR Iran.
Neda AsghariDepartment of Psychiatry, Kerman University of Medical Sciences, Kerman, IR Iran.
Nozar NakhaeeKerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, IR Iran.
Mahin EslamiDepartment of Psychiatry, Kerman University of Medical Sciences, Kerman, IR Iran.
Kerman University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance abuse or drug addiction is one of the most important health issues in every society, which can lead to physical and mental problems.

objectivesThis study aimed to compare the efficacy of tramadol plus gabapentin versus methadone use in the treatment of opiate withdrawal. PATIENTS AND

methodsConsenting male subjects who fulfilled the DSM-4 criteria for opiate dependence syndrome (opium, residue, and heroin) were randomly assigned in two groups to receive tramadol plus gabapentin or methadone. Assessment tools were Adjective Rating Scale for Withdrawal (ARSW), Clinical Opiate Withdrawal Scale (COWS) and Visual Analogue craving Scale (VAS). Fifty-nine subjects were enrolled and evaluated on days 1, 2, 3, 4, 6, and 8 during their 10 days of admission. Twenty-nine participants received methadone and the other 30 received tramadol plus gabapentin for their treatment.

resultsMean (SD) age of the patients in methadone group and tramadol plus gabapentin group were 33.9 (7.1) and 32.4. (8.1), respectively (P = 0.462). The overall ARSW (P value = 0.263) and COWS (P = 0.862) scores between the two groups were comparable. The differences in the VAS score for craving between the two groups was marginally significant (P = 0.057). The highest VAS score was at the third day of admission in both groups and it was generally higher in methadone group.

conclusionsThe severity of withdrawal syndrome in two groups was not significantly different. The craving was higher in the group receiving methadone from the second day of admission even though the usage amount was higher in the tramadol plus gabapentin group. The findings of this study suggest that the combination of tramadol plus gabapentin is an efficient method for opioid detoxification.

Indexed as

HumansMethadoneOpioidRandomized Controlled TrialTramadol

Identifiers

PMID25763266
PMCPMC4341495
OpenAlexW2126298280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.